266 related articles for article (PubMed ID: 12124355)
41. Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: a report from the Radiation Therapy Oncology Group.
Chakravarti A; Winter K; Wu CL; Kaufman D; Hammond E; Parliament M; Tester W; Hagan M; Grignon D; Heney N; Pollack A; Sandler H; Shipley W
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):309-17. PubMed ID: 15890569
[TBL] [Abstract][Full Text] [Related]
42. Expression of cathepsin D in urothelial carcinoma of the urinary bladder: an immunohistochemical study including correlations with extracellular matrix components, CD44, p53, Rb, c-erbB-2 and the proliferation indices.
Ioachim E; Charchanti A; Stavropoulos N; Athanassiou E; Bafa M; Agnantis NJ
Anticancer Res; 2002; 22(6A):3383-8. PubMed ID: 12530091
[TBL] [Abstract][Full Text] [Related]
43. New insights into the influence of cigarette smoking on urothelial carcinogenesis: smoking-induced gene expression in tumor-free urothelium might discriminate muscle-invasive from nonmuscle-invasive urothelial bladder cancer.
Gabriel U; Li L; Bolenz C; Steidler A; Kränzlin B; Saile M; Gretz N; Trojan L; Michel MS
Mol Carcinog; 2012 Nov; 51(11):907-15. PubMed ID: 21976419
[TBL] [Abstract][Full Text] [Related]
44. Flow cytometric detection and quantitation of the epidermal growth factor receptor in comparison to Scatchard analysis in human bladder carcinoma cell lines.
Brockhoff G; Hofstaedter F; Knuechel R
Cytometry; 1994 Sep; 17(1):75-83. PubMed ID: 8001460
[TBL] [Abstract][Full Text] [Related]
45. Expression of vascular endothelial growth inhibitor (VEGI) in human urothelial cancer of the bladder and its effects on the adhesion and migration of bladder cancer cells in vitro.
Zhang N; Sanders AJ; Ye L; Kynaston HG; Jiang WG
Anticancer Res; 2010 Jan; 30(1):87-95. PubMed ID: 20150621
[TBL] [Abstract][Full Text] [Related]
46. Prognostic significance of epidermal growth factor receptor (EGFR) over expression in urothelial carcinoma of urinary bladder.
Hashmi AA; Hussain ZF; Irfan M; Khan EY; Faridi N; Naqvi H; Khan A; Edhi MM
BMC Urol; 2018 Jun; 18(1):59. PubMed ID: 29879970
[TBL] [Abstract][Full Text] [Related]
47. FGFR3b Extracellular Loop Mutation Lacks Tumorigenicity In Vivo but Collaborates with p53/pRB Deficiency to Induce High-grade Papillary Urothelial Carcinoma.
Zhou H; He F; Mendelsohn CL; Tang MS; Huang C; Wu XR
Sci Rep; 2016 May; 6():25596. PubMed ID: 27157475
[TBL] [Abstract][Full Text] [Related]
48. Betacellulin transgenic mice develop urothelial hyperplasia and show sex-dependent reduction in urinary major urinary protein content.
Schulz H; Dahlhoff M; Glogowska A; Zhang L; Arnold GJ; Fröhlich T; Schneider MR; Klonisch T
Exp Mol Pathol; 2015 Aug; 99(1):33-8. PubMed ID: 25943456
[TBL] [Abstract][Full Text] [Related]
49. Loss of p53 and acquisition of angiogenic microRNA profile are insufficient to facilitate progression of bladder urothelial carcinoma in situ to invasive carcinoma.
Ayala de la Peña F; Kanasaki K; Kanasaki M; Tangirala N; Maeda G; Kalluri R
J Biol Chem; 2011 Jun; 286(23):20778-87. PubMed ID: 21388952
[TBL] [Abstract][Full Text] [Related]
50. Urothelial tumor initiation requires deregulation of multiple signaling pathways: implications in target-based therapies.
Zhou H; Huang HY; Shapiro E; Lepor H; Huang WC; Mohammadi M; Mohr I; Tang MS; Huang C; Wu XR
Carcinogenesis; 2012 Apr; 33(4):770-80. PubMed ID: 22287562
[TBL] [Abstract][Full Text] [Related]
51. Deficiency of pRb family proteins and p53 in invasive urothelial tumorigenesis.
He F; Mo L; Zheng XY; Hu C; Lepor H; Lee EY; Sun TT; Wu XR
Cancer Res; 2009 Dec; 69(24):9413-21. PubMed ID: 19951992
[TBL] [Abstract][Full Text] [Related]
52. Maintenance of the bladder cancer precursor urothelial hyperplasia requires FOXA1 and persistent expression of oncogenic HRAS.
Yee CH; Zheng Z; Shuman L; Yamashita H; Warrick JI; Wu XR; Raman JD; DeGraff DJ
Sci Rep; 2019 Jan; 9(1):270. PubMed ID: 30670749
[TBL] [Abstract][Full Text] [Related]
53. Proliferative state of the urothelium with benign and atypical changes. Correlation with transferrin and epidermal growth factor receptors and blood group antigens.
Limas C
J Pathol; 1993 Sep; 171(1):39-47. PubMed ID: 8229455
[TBL] [Abstract][Full Text] [Related]
54. The epidermal growth factor receptor is involved in autocrine growth of human bladder carcinoma cell lines.
Ruck A; Paulie S
Anticancer Res; 1997; 17(3C):1925-31. PubMed ID: 9216646
[TBL] [Abstract][Full Text] [Related]
55. Restoration of the rat urothelium after cyclophosphamide treatment.
Romih R; Koprivec D; Martincic DS; Jezernik K
Cell Biol Int; 2001; 25(6):531-7. PubMed ID: 11407858
[TBL] [Abstract][Full Text] [Related]
56. An in vitro model of urothelial regeneration: effects of growth factors and extracellular matrix proteins.
Rebel JM; De Boer WI; Thijssen CD; Vermey M; Zwarthoff EC; Van der Kwast TH
J Pathol; 1994 Jul; 173(3):283-91. PubMed ID: 7523645
[TBL] [Abstract][Full Text] [Related]
57. P16, c-erbB2 and Ki67 immunoexpression in urothelial carcinomas of the bladder.
Stepan A; Simionescu C; Mărgăritescu C; Ciurea R
Rom J Morphol Embryol; 2011; 52(2):653-8. PubMed ID: 21655657
[TBL] [Abstract][Full Text] [Related]
58. Growth of normal and neoplastic urothelium and response to epidermal growth factor in a defined serum-free medium.
Dubeau L; Jones PA
Cancer Res; 1987 Apr; 47(8):2107-12. PubMed ID: 3493840
[TBL] [Abstract][Full Text] [Related]
59. Epidermal growth factor receptor function in the human urothelium.
Wasén C; Ekstrand M; Levin M; Giglio D
Int Urol Nephrol; 2018 Apr; 50(4):647-656. PubMed ID: 29508172
[TBL] [Abstract][Full Text] [Related]
60. Enhancing detection of bladder carcinoma in situ by 3-dimensional optical coherence tomography.
Ren H; Yuan Z; Waltzer W; Shroyer K; Pan Y
J Urol; 2010 Oct; 184(4):1499-506. PubMed ID: 20723922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
